Solasia Pharma K.K. (TYO:4597)
Japan
· Delayed Price · Currency is JPY 32.00
-1.00 (-3.03%)
Apr 24, 2025, 3:30 PM JST
Solasia Pharma K.K. Revenue
In the year 2024, Solasia Pharma K.K. had annual revenue of 316.00M JPY, down -48.78%. Solasia Pharma K.K. had revenue of 235.00M in the quarter ending December 31, 2024, with 1,466.67% growth.
Revenue
316.00M
Revenue Growth
-48.78%
P/S Ratio
22.08
Revenue / Employee
13.74M
Employees
23
Market Cap
6.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 316.00M | -301.00M | -48.78% |
| Dec 31, 2023 | 617.00M | -475.00M | -43.50% |
| Dec 31, 2022 | 1.09B | 533.00M | 95.35% |
| Dec 31, 2021 | 559.00M | 105.00M | 23.13% |
| Dec 31, 2020 | 454.00M | -856.00M | -65.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Shionogi & | 456.87B |